Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

News Details

29/05/2026 20:50

Concord Biotech Q4 net profit down 36.58% at Rs 90.02 cr

The company reported standalone net profit of Rs 90.02 crore for the quarter ended March 31, 2026 as compared to Rs 141.94 crore in the same period last year, registering a year-on-year decline of 36.58 per cent.

Net revenue of the company declined substantially by 24.19 per cent at Rs 325.89 crore in January-March quarter of this fiscal as against Rs 429.88 crore in the corresponding period last year.

During January-March quarter, operating expenses dropped by 15.01 per cent to Rs 203.51 crore from Rs 239.46 crore in year ago period.

Other Income grew by 65.67 per cent at Rs 15.54 crore versus (Mar'25 Rs 9.38 crore).

Operating Profit slipped by 35.73 per cent to Rs 122.38 crore as against Rs 190.42 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 15.24 per cent in March quarter.

Interest declined by 40.00 per cent y-o-y to Rs 0.06 crore, while Taxation decreased by 34.29 per cent at Rs 28.36 crore (Mar'25 Rs 43.16 crore).